Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

Determining Value in Health Technology Assessment: Stay the Course or Tack Away?

Caro JJ, Brazier JE, Karnon J, Kolominsky-Rabas P, McGuire AJ, Nord E, Schlander M.

Pharmacoeconomics. 2018 Nov 9. doi: 10.1007/s40273-018-0742-2. [Epub ahead of print]

PMID:
30414074
2.

Including Future Consumption and Production in Economic Evaluation of Interventions that Save Life-Years: Commentary.

Nord E, Lamøy C.

Pharmacoecon Open. 2018 Dec;2(4):357-358. doi: 10.1007/s41669-018-0079-y. No abstract available.

3.

A Behavioral Survey of the Effects of Kavalactones on Caenorhabditis elegans Neuromuscular Transmission.

Kautu BB, Phillips J, Steele K, Mengarelli MS, Nord EA.

J Exp Neurosci. 2017 Jun 5;11:1179069517705384. doi: 10.1177/1179069517705384. eCollection 2017.

4.

Thromboembolism and in vitro fertilization - a systematic review.

Sennström M, Rova K, Hellgren M, Hjertberg R, Nord E, Thurn L, Lindqvist PG.

Acta Obstet Gynecol Scand. 2017 Sep;96(9):1045-1052. doi: 10.1111/aogs.13147. Epub 2017 Jun 8. Review.

PMID:
28382684
5.

5 Years Experience With Drug Eluting and Bare Metal Stents as Primary Intervention in Transplant Renal Artery Stenosis.

Estrada CC, Musani M, Darras F, Suh H, Abate MT, Mani A, Nord EP.

Transplant Direct. 2017 Jan 17;3(2):e128. doi: 10.1097/TXD.0000000000000643. eCollection 2017 Feb.

6.

Beyond QALYs: Multi-criteria based estimation of maximum willingness to pay for health technologies.

Nord E.

Eur J Health Econ. 2018 Mar;19(2):267-275. doi: 10.1007/s10198-017-0882-x. Epub 2017 Mar 3.

PMID:
28258399
7.

Phosphorylation-specific status of RNAi triggers in pharmacokinetic and biodistribution analyses.

Trubetskoy VS, Griffin JB, Nicholas AL, Nord EM, Xu Z, Peterson RM, Wooddell CI, Rozema DB, Wakefield DH, Lewis DL, Kanner SB.

Nucleic Acids Res. 2017 Feb 17;45(3):1469-1478. doi: 10.1093/nar/gkw828.

8.

Determining the value of medical technologies to treat ultra-rare disorders: a consensus statement.

Schlander M, Garattini S, Kolominsky-Rabas P, Nord E, Persson U, Postma M, Richardson J, Simoens S, de Solà-Morales O, Tolley K, Toumi M.

J Mark Access Health Policy. 2016 Oct 27;4. doi: 10.3402/jmahp.v4.33039. eCollection 2016.

9.

Krüppel-Like Factor 15 Mediates Glucocorticoid-Induced Restoration of Podocyte Differentiation Markers.

Mallipattu SK, Guo Y, Revelo MP, Roa-Peña L, Miller T, Ling J, Shankland SJ, Bialkowska AB, Ly V, Estrada C, Jain MK, Lu Y, Ma'ayan A, Mehrotra A, Yacoub R, Nord EP, Woroniecki RP, Yang VW, He JC.

J Am Soc Nephrol. 2017 Jan;28(1):166-184. doi: 10.1681/ASN.2015060672. Epub 2016 Jun 10.

10.

Uncertainties about disability weights for the Global Burden of Disease study.

Nord E.

Lancet Glob Health. 2015 Nov;3(11):e661-2. doi: 10.1016/S2214-109X(15)00189-8. No abstract available.

11.

[Re: Age and severity].

Nord E.

Tidsskr Nor Laegeforen. 2015 Sep 22;135(17):1529-30. doi: 10.4045/tidsskr.15.0909. eCollection 2015 Sep 22. Norwegian. No abstract available.

12.

[E. Nord replies].

Nord E.

Tidsskr Nor Laegeforen. 2015 Sep 8;135(16):1432. doi: 10.4045/tidsskr.15.0838. eCollection 2015 Sep 8. Norwegian. No abstract available.

13.

Randomized controlled study in pregnancy on treatment of marked hyperglycemia that is short of overt diabetes.

Fadl HE, Gärdefors S, Hjertberg R, Nord E, Persson B, Schwarcz E, Åman J, Östlund IK, Hanson US.

Acta Obstet Gynecol Scand. 2015 Nov;94(11):1181-7. doi: 10.1111/aogs.12717. Epub 2015 Aug 29.

PMID:
26222270
14.

Response to elevated CO2 in the temperate C3 grass Festuca arundinaceae across a wide range of soils.

Nord EA, Jaramillo RE, Lynch JP.

Front Plant Sci. 2015 Feb 24;6:95. doi: 10.3389/fpls.2015.00095. eCollection 2015.

15.

Cost-value analysis of health interventions: introduction and update on methods and preference data.

Nord E.

Pharmacoeconomics. 2015 Feb;33(2):89-95. doi: 10.1007/s40273-014-0212-4.

PMID:
25488879
16.

[Markov modeling].

Nord E.

Tidsskr Nor Laegeforen. 2014 Nov 11;134(21):2062-5. doi: 10.4045/tidsskr.14.0116. eCollection 2014 Nov 11. Norwegian. No abstract available.

17.

The Evaluation of Economic Methods to Assess the Social Value of Medical Interventions for Ultra-Rare Disorders (URDS).

Schlander M, Garattini S, Holm S, Kolominsky-Rabas PL, Nord E, Persson U, Postma MJ, Richardson J, Simoens S, de Sola-Morales O, Tolley K, Toumi M.

Value Health. 2014 Nov;17(7):A324. doi: 10.1016/j.jval.2014.08.570. Epub 2014 Oct 26. No abstract available.

18.

Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders.

Schlander M, Garattini S, Holm S, Kolominsky-Rabas P, Nord E, Persson U, Postma M, Richardson J, Simoens S, de Solà Morales O, Tolley K, Toumi M.

J Comp Eff Res. 2014 Jul;3(4):399-422. doi: 10.2217/cer.14.34.

PMID:
25275236
19.

Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysis.

Norheim OF, Baltussen R, Johri M, Chisholm D, Nord E, Brock D, Carlsson P, Cookson R, Daniels N, Danis M, Fleurbaey M, Johansson KA, Kapiriri L, Littlejohns P, Mbeeli T, Rao KD, Edejer TT, Wikler D.

Cost Eff Resour Alloc. 2014 Aug 29;12:18. doi: 10.1186/1478-7547-12-18. eCollection 2014.

20.

[Venous thrombosis in pregnancy and assisted reproduction. Updated recommendations on risk assessment and indications for thromboprophylaxis].

Lindqvist PG, Rova K, Thurn L, Wegnelius G, Nord E, Hellgren M.

Lakartidningen. 2014 Aug 6-19;111(32-33):1305-8. Review. Swedish. No abstract available.

21.

Image-based high-throughput field phenotyping of crop roots.

Bucksch A, Burridge J, York LM, Das A, Nord E, Weitz JS, Lynch JP.

Plant Physiol. 2014 Oct;166(2):470-86. doi: 10.1104/pp.114.243519. Epub 2014 Sep 3.

22.

Root cortical aerenchyma enhances nitrogen acquisition from low-nitrogen soils in maize.

Saengwilai P, Nord EA, Chimungu JG, Brown KM, Lynch JP.

Plant Physiol. 2014 Oct;166(2):726-35. doi: 10.1104/pp.114.241711. Epub 2014 Jun 2.

23.

[Re: Rarity--a separate criterion used in prioritization?].

Nord E.

Tidsskr Nor Laegeforen. 2014 Apr 29;134(8):809. doi: 10.4045/tidsskr.14.0454. eCollection 2014 Apr 29. Norwegian. No abstract available.

24.

Concerns for severity in priority setting in health care: a review of trade-off data in preference studies and implications for societal willingness to pay for a QALY.

Nord E, Johansen R.

Health Policy. 2014 Jun;116(2-3):281-8. doi: 10.1016/j.healthpol.2014.02.009. Epub 2014 Feb 28. Review.

PMID:
24690334
25.

Transforming EQ-5D utilities for use in cost–value analysis of health programs.

Nord E, Johansen R.

Eur J Health Econ. 2015 Apr;16(3):313-28.

PMID:
24659019
26.

Arteriojejunal Fistula Presenting with Recurrent Obscure GI Hemorrhage in a Patient with a Failed Pancreas Allograft.

Desai N, Patel S, Nwosu C, Sung L, Tack C, Buscaglia JM, Nord EP, Wadhwa NK.

Case Rep Transplant. 2013;2013:171807. doi: 10.1155/2013/171807. Epub 2013 Dec 25.

27.

Integration of root phenes for soil resource acquisition.

York LM, Nord EA, Lynch JP.

Front Plant Sci. 2013 Sep 12;4:355. doi: 10.3389/fpls.2013.00355. eCollection 2013.

28.

Root cortical burden influences drought tolerance in maize.

Jaramillo RE, Nord EA, Chimungu JG, Brown KM, Lynch JP.

Ann Bot. 2013 Jul;112(2):429-37. doi: 10.1093/aob/mct069. Epub 2013 Apr 25.

29.

Disability weights in the Global Burden of Disease 2010: unclear meaning and overstatement of international agreement.

Nord E.

Health Policy. 2013 Jun;111(1):99-104. doi: 10.1016/j.healthpol.2013.03.019. Epub 2013 Apr 19.

PMID:
23608637
30.

[Not unclear about severity of illness].

Nord E.

Tidsskr Nor Laegeforen. 2013 Mar 5;133(5):499-500. doi: 10.4045/tidsskr.13.0182. Norwegian. No abstract available.

31.

Invasive aspergillosis in a renal transplant recipient successfully treated with interferon-gamma.

Estrada C, Desai AG, Chirch LM, Suh H, Seidman R, Darras F, Nord EP.

Case Rep Transplant. 2012;2012:493758. doi: 10.1155/2012/493758. Epub 2012 Sep 27.

32.

Reversible left ventricular dysfunction and acute kidney injury in a patient with nonamyloid light chain deposition disease.

Wadhwa NK, Kamra A, Skopicki HA, Richard S, Miller F, Nord EP.

Clin Nephrol. 2012 Dec;78(6):501-5.

PMID:
23164419
33.

Intestinal infarction and portal vein thrombosis in a patient with henoch schonlein purpura.

Abebe M, Patnaik A, Miller F, Roppelt H, Wadhwa NK, Abate M, Nord EP.

Case Rep Rheumatol. 2012;2012:672959. doi: 10.1155/2012/672959. Epub 2012 Oct 14.

34.
35.

Measuring concerns for severity: re-examination of a health scale with purported equal interval properties.

Nord E.

Health Policy. 2012 May;105(2-3):312-6. doi: 10.1016/j.healthpol.2012.02.017. Epub 2012 Mar 22.

PMID:
22444761
36.

Retroperitoneal mass in a patient with Wegener's granulomatosis.

Kaur J, Miller F, Wadhwa NK, Nord EP.

Clin Nephrol. 2012 Mar;77(3):237-41.

PMID:
22377256
37.

The use of drug-eluting stents in the management of transplant renal artery stenosis.

Abate MT, Kaur J, Suh H, Darras F, Mani A, Nord EP.

Am J Transplant. 2011 Oct;11(10):2235-41. doi: 10.1111/j.1600-6143.2011.03652.x. Epub 2011 Aug 9.

38.
39.

Discounting future health benefits: the poverty of consistency arguments.

Nord E.

Health Econ. 2011 Jan;20(1):16-26. doi: 10.1002/hec.1687. Epub 2010 Nov 11.

PMID:
21154522
40.

IQWiG methods--a response to two critiques.

Caro JJ, Nord E, Siebert U, McGuire A, McGregor M, Henry D, de Pouvourville G, Atella V, Kolominsky-Rabas P.

Health Econ. 2010 Oct;19(10):1137-8. doi: 10.1002/hec.1658. No abstract available.

PMID:
20842681
41.

Quiz page: acute kidney injury secondary to bilateral ureteral obstruction.

Kaur J, Nord EP, Wadhwa NK.

Am J Kidney Dis. 2010 Aug;56(2):A33-5. doi: 10.1053/j.ajkd.2009.09.016. No abstract available.

PMID:
20659622
42.

The efficiency frontier approach to economic evaluation of health-care interventions.

Caro JJ, Nord E, Siebert U, McGuire A, McGregor M, Henry D, de Pouvourville G, Atella V, Kolominsky-Rabas P.

Health Econ. 2010 Oct;19(10):1117-27. doi: 10.1002/hec.1629.

PMID:
20575151
43.

Socio-demographic, psychosocial and health characteristics of Norwegian senior centre users: a cross-sectional study.

Bøen H, Dalgard OS, Johansen R, Nord E.

Scand J Public Health. 2010 Jul;38(5):508-17. doi: 10.1177/1403494810370230. Epub 2010 May 19.

PMID:
20484305
44.

Balancing relevant criteria in allocating scarce life-saving interventions.

Nord E.

Am J Bioeth. 2010 Apr;10(4):56-8. doi: 10.1080/15265161003633045. No abstract available.

PMID:
20379926
45.

Uterine leiomyoma causing urinary obstruction of the transplanted kidney.

Abate M, Wadhwa NK, Nord EP.

Clin Nephrol. 2010 Apr;73(4):314-7.

PMID:
20353740
46.

QALYs: is the value of treatment proportional to the size of the health gain?

Nord E, Enge AU, Gundersen V.

Health Econ. 2010 May;19(5):596-607. doi: 10.1002/hec.1497.

PMID:
19459186
47.

Plant phenology: a critical controller of soil resource acquisition.

Nord EA, Lynch JP.

J Exp Bot. 2009;60(7):1927-37. doi: 10.1093/jxb/erp018. Epub 2009 Mar 13. Review.

PMID:
19286918
48.

Toward a consensus on the QALY.

Drummond M, Brixner D, Gold M, Kind P, McGuire A, Nord E; Consensus Development Group.

Value Health. 2009 Mar;12 Suppl 1:S31-5. doi: 10.1111/j.1524-4733.2009.00522.x. No abstract available.

49.

QALYs: some challenges.

Nord E, Daniels N, Kamlet M.

Value Health. 2009 Mar;12 Suppl 1:S10-5. doi: 10.1111/j.1524-4733.2009.00516.x. No abstract available.

50.

IL-8 amplifies CD40/CD154-mediated ICAM-1 production via the CXCR-1 receptor and p38-MAPK pathway in human renal proximal tubule cells.

Li H, Nord EP.

Am J Physiol Renal Physiol. 2009 Feb;296(2):F438-45. doi: 10.1152/ajprenal.90214.2008. Epub 2008 Jul 30.

Supplemental Content

Support Center